Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Immunome (IMNM) Asset Utilization Ratio (2023 - 2025)

Immunome (IMNM) has disclosed Asset Utilization Ratio for 3 consecutive years, with 0.01 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 61.16% year-over-year to 0.01, compared with a TTM value of 0.01 through Dec 2025, down 61.16%, and an annual FY2025 reading of 0.02, down 67.68% over the prior year.
  • Asset Utilization Ratio was 0.01 for Q4 2025 at Immunome, down from 0.03 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.12 in Q4 2023 and bottomed at 0.01 in Q4 2025.
  • Average Asset Utilization Ratio over 3 years is 0.04, with a median of 0.04 recorded in 2024.
  • The sharpest move saw Asset Utilization Ratio crashed 68.64% in 2024, then increased 12.53% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.12 in 2023, then plummeted by 68.64% to 0.04 in 2024, then crashed by 61.16% to 0.01 in 2025.
  • Business Quant data shows Asset Utilization Ratio for IMNM at 0.01 in Q4 2025, 0.03 in Q3 2025, and 0.04 in Q2 2025.